The efficacy and safety of dipeptidyl peptidase-4 inhibitors for type 2 diabetes: A Bayesian network meta-analysis of 58 randomized controlled trials - Ling, J; Cheng, P; Ge, L (Acta Diabetologica, 2019)
et al.